Latest News about GSK
Recent news which mentions GSK
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
April 13, 2023
From Motley Fool
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
From Motley Fool
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
2 Top Biotech Stocks to Buy in April
April 04, 2023
From Motley Fool
From Motley Fool
Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis
March 31, 2023
From Benzinga
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
March 31, 2023
From Benzinga
From Benzinga
Why Is Scynexis (SCYX) Stock Up 69% Today?
March 30, 2023
From InvestorPlace
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug
March 30, 2023
From Benzinga
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
March 29, 2023
From Benzinga
GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients
March 28, 2023
From Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
From Benzinga
From Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
From Benzinga
From InvestorPlace
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
March 17, 2023
From Motley Fool
GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales
March 15, 2023
From Benzinga
From InvestorPlace
Tickers
GSK
From Motley Fool
FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's
March 02, 2023
From Benzinga
3 Crucial Things to Know About Moderna Right Now
February 27, 2023
From Motley Fool
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
February 24, 2023
Tickers
GSK
From Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields
February 23, 2023
From Benzinga
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows
February 23, 2023
From Benzinga
Intel and 9 Other Companies With Dividend Cuts in 2023
February 22, 2023
From InvestorPlace
My 3 Biggest Stock Market Predictions for March
February 21, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.